Arcus Biosciences, Inc. (RCUS)

NYSE

$22.50

$-1.83

(-7.52%)

After-Hours

Arcus Biosciences, Inc. (RCUS) Live Price Chart

Last updated: ⁦2026-10-13 20:50:20⁩. Prices reflect the latest after-hours trading data. Stock price data is sourced from Massive.

Summary

Arcus Biosciences, Inc. (RCUS) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NYSE. The stock is currently priced at $22.50, with a market capitalization of $3.11B and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $15.09 to $31.74. This page covers its latest market performance, valuation, price trends and company information.

Key Market Data

Market Cap	$3.11B
Open	$23.87
Day's High	$49.10
Day's Low	$6.30
Previous Close	$24.34
Volume	1.10M
Average Volume	1.36M
P/E Ratio	--
52-Week High	$31.74
52-Week Low	$15.09
Dividend Yield	--
Earnings Date	--

Arcus Biosciences, Inc. (RCUS) After-Hours Stock Price

Arcus Biosciences, Inc. (RCUS) is trading at $22.50 in after-hours trading as of 2026-10-13 20:49:00, down 7.58% ($1.84) from the regular-session close of $24.34.

After-hours trading shows how investors are pricing RCUS after the regular session closes. The current after-hours price is below the regular-session close, indicating cautious after-hours sentiment.

Arcus Biosciences, Inc. (RCUS) 7-Day Stock Price Change

Over the past seven days, Arcus Biosciences, Inc. (RCUS) moved from $24.44 to $22.50, representing a decline of 7.95% ($1.94).

The stock traded between $22.49 and $25.58 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.

The average daily volume was 1.27 million shares, down versus the previous seven-day period, indicating lower trading activity.

RCUS 52-Week Price Position

Position in Range: 44.5%

52W Low$15.09

52W High$31.74

RCUS is currently trading at $22.50, placing it 44.5% of the way from its 52-week low of $15.09 to its 52-week high of $31.74. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.

What is Arcus Biosciences, Inc. (RCUS)?

Arcus Biosciences Inc is a late clinical-stage biopharmaceutical company focused on developing differentiated molecules for patients with cancer and inflammatory and autoimmune diseases. Its product pipeline includes Domvanalimab, Quemliclustat, Casdatifan, Zimberelimab, among others. The company operates in one reportable and operating segment, which is the business of developing and commercializing differentiated therapies.

Arcus Biosciences, Inc. Information

Industry	PHARMACEUTICAL PREPARATIONS
Employees	601
Exchange	NYSE
Company Website	https://www.arcusbio.com

How to Buy Arcus Biosciences, Inc. (RCUS) Stock on MEXC

Eligible investors can buy real shares of Arcus Biosciences, Inc. (RCUS) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.

Step 1: Open and Verify Your RealStocks Account

Log in to the MEXC App, go to Trade → RealStocks, and select Open Account. Complete the required account-opening and identity verification process with MEXC's partner licensed broker.

Step 2: Transfer USDT to Your RealStocks Account

Go to Wallets → RealStocks and transfer USDT from your Spot Account to your RealStocks Account. RealStocks are quoted in USD, while account funding can be completed using USDT.

Step 3: Search for RCUS and Place Your Order

Open the RealStocks trading page and search for RCUS. Select a market or limit order, enter the price and quantity as required, review the order details, and submit your order. Once filled, the corresponding real shares will be held in your RealStocks Account.

Frequently Asked Questions (FAQ)

1.What is Arcus Biosciences, Inc. (RCUS) stock price today?

Arcus Biosciences, Inc. (RCUS) is currently trading at $ 22.50, down 7.57% ($1.84) from the previous close of $ 24.34. Intraday prices update in real time during regular trading hours.

2.Is RCUS stock going up or down today?

As of 2026-10-13 20:49:00, RCUS is trading at $ 22.50, down 7.57% ($1.84) from its previous close of $ 24.34. The stock has traded between $ 6.30 and $ 49.10 during today’s regular session. Past price movements do not guarantee future results.

3.What is RCUS pre-market price?

As of 2026-10-13 20:49:00, RCUS is trading at $ 24.50 in pre-market trading, up 0.66% ($0.16) from the previous close of $ 24.34. Pre-market prices reflect trading activity before the regular session opens and may experience lower liquidity and higher volatility.

4.What is RCUS after-hours price?

As of 2026-10-13 20:49:00, RCUS is trading at $ 22.50 in after-hours trading, down 7.58% ($1.84) from the regular-session close of $ 24.34. After-hours prices may differ from the regular session’s opening price due to lower liquidity and wider bid-ask spreads.

5.Is RCUS stock trading now?

RCUS trades on the NYSE exchange during regular hours, Monday through Friday, 9:30 AM to 4:00 PM ET, excluding public holidays. Pre-market and after-hours trading are also available through select brokers outside these hours.

6.Where does RCUS sit relative to its 52-week high and low?

Over the past 52 weeks, RCUS has traded between a low of $ 15.09 and a high of $ 31.74. At $ 22.50, the stock is positioned 44.5% of the way from its 52-week low to its 52-week high, providing context for its current price within the one-year trading range.

7.What sector is Arcus Biosciences, Inc. in?

Arcus Biosciences, Inc. (RCUS) operates in the PHARMACEUTICAL PREPARATIONS sector. Sector classification helps investors compare it with companies exposed to similar market trends and competitive conditions.

8.What is Arcus Biosciences, Inc.'s market capitalization and where is it listed?

Arcus Biosciences, Inc. is listed on the NYSE exchange with a market capitalization of $ 3.11B. Market cap reflects the total market value of all outstanding shares and is commonly used to classify stocks by size.

9.How is RCUS valued in terms of P/E ratio and EPS?

RCUS trades at a P/E ratio of --, based on trailing-twelve-month EPS of $ -3.61. P/E ratio compares the stock price to earnings per share and is a common starting point for assessing valuation relative to peers.

10.Does Arcus Biosciences, Inc. pay a dividend?

Arcus Biosciences, Inc. pays an indicated annual cash dividend of $ 0.00 per share, with a current dividend yield of 0.00% based on the latest share price. Dividend policies are subject to change at the board's discretion.